Oregon Public Employees Retirement Fund Vir Biotechnology, Inc. Transaction History
Oregon Public Employees Retirement Fund
- $5.08 Billion
- Q3 2024
A detailed history of Oregon Public Employees Retirement Fund transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 21,568 shares of VIR stock, worth $153,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,568
Previous 21,168
1.89%
Holding current value
$153,564
Previous $188,000
14.36%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VIR
# of Institutions
219Shares Held
87.4MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$119 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$117 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$93.5 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$40.1 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$25.4 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $944M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...